Connection
David Camidge to Meningeal Neoplasms
This is a "connection" page, showing publications David Camidge has written about Meningeal Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.380 |
|
|
|
-
PiƱa Y, Umeh Garcia M, Boire A, Brenner A, Camidge DR, Chang S, Forsyth PA, Hayden Gephart M, Olayinka Kamson D, Kumthekar P, Quant Lee E, Le Rhun E, O'Brien B, Pentsova E, Piccioni D, Remsik J, Smalley I, Wefel J, Weller M, Wilcox J, Yang JT, Nagpal S, Glitza Oliva IC. Breaking barriers in leptomeningeal disease: A Society for Neuro-Oncology and The American Society of Clinical Oncology consensus review on clinical trial design and basic science integration. Neuro Oncol. 2026 Oct 01; 28(10):2299-2312.
Score: 0.224
-
Tsui DCC, Kavanagh BD, Honce JM, Rossi C, Patil T, Camidge DR. Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib. Clin Lung Cancer. 2022 01; 23(1):e5-e8.
Score: 0.155
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|